Predictors of Antihypertensive Drug Responses: Initial Data from a Placebo-Controlled, Randomized, Cross-Over Study With Four Antihypertensive Drugs (The GENRES Study)

American Journal of Hypertension

Volumn 20, Issue 3, 2007, Pages 311-318

  Hiltunen, Timo P ^a,b   Suonsyrjä, Timo ^a   Hannila Handelberg, Tuula ^a   Paavonen, Kristian J ^a   Miettinen, Helena E ^a   Strandberg, Timo ^a   Tikkanen, Ilkka ^a   Tilvis, Reijo ^a   Pentikäinen, Pertti J ^a   Virolainen, Juha ^a   Kontula, Kimmo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b JORVI HOSPITAL   (Finland)

Author keywords

blood pressure determination; drug therapy; Hypertension; pharmacogenetics

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BISOPROLOL FUMARATE; CALCIUM CHANNEL BLOCKING AGENT; HYDREX; HYDROCHLOROTHIAZIDE; LOSARTAN; LOSARTAN POTASSIUM; PLACEBO; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FAMILY HISTORY; FINLAND; GENETIC VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKINFOLD; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TRICEPS BRACHII MUSCLE; UNSPECIFIED SIDE EFFECT; WAIST HIP RATIO;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DIURETICS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FINLAND; GENOTYPE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TREATMENT OUTCOME; VARIATION (GENETICS);

EID: 33847183510     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.09.006     Document Type: Article

References (30)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., Roccella E.J., and National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
2. Kaplan N.M., and Opie L.H. Controversies in hypertension. Lancet 367 (2006) 168-176
3. Laragh J. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 14 (2001) 491-503
4. Koopmans R.P., Insel P.A., and Michel M.C. Pharmacogenetics of hypertension treatment: a structured review. Pharmacogenetics 13 (2003) 705-713
5. Turner S.T., and Boerwinkle E. Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses. Pharmacogenomics 4 (2003) 53-65
6. Mellen P.B., and Herrington D.M. Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens 23 (2005) 1311-1325
7. Kurland L., Lind L., and Melhus H. Using genotyping to predict responses to anti-hypertensive treatment. Trends Pharmacol Sci 26 (2005) 443-447
8. Hingorani A.D., Jia H., Stevens P.A., Hopper R., Dickerson J.E., and Brown M.J. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 13 (1995) 1602-1609
9. Hunt S.C., Cook N.R., Oberman A., Cutler J.A., Hennekens C.H., Allender P.S., Walker W.G., Whelton P.K., and Williams R.R. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension 32 (1998) 393-401
10. O'Brien E., Asmar R., Beilin L., Imai Y., Mallion J.M., Mancia G., Mengden T., Myers M., Padfield P., Palatini P., Parati G., Pickering T., Redon J., Staessen J., Stergiou G., Verdecchia P., and European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 21 (2003) 821-848
11. Deary A.J., Schumann A.L., Murfet H., Haydock S.F., Foo R.S., and Brown M.J. Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs. J Hypertens 20 (2002) 771-777
12. Bidiville J., Nussberger J., Waeber G., Porchet M., Waeber B., and Brunner H.R. Individual responses to converting enzyme inhibitors and calcium antagonists. Hypertension 11 (1988) 166-173
13. Chalmers J., Wing L., and Taylor S. Analysis of time trends, individual subject responses and background variation in crossover factorial studies with antihypertensive drugs. J Hypertens 8 Suppl 4 (1990) S27-S35
14. Niutta E., Cusi D., Colombo R., Pellizzoni M., Cesana B., Barlassina C., Soldati L., and Bianchi G. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin. J Hypertens 8 Suppl 4 (1990) S53-S58
15. Cappuccio F.P., Markandu N.D., Singer D.R., and MacGregor G.A. Amlodipine and lisinopril in combination for the treatment of essential hypertension: efficacy and predictors of response. J Hypertens 11 (1993) 839-847
16. Attwood S., Bird R., Burch K., Casadei B., Coats A., Conway J., Dawes M., Ebbs D., Farmer A., and Robinson J. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine. J Hypertens 12 (1994) 1053-1060
17. Dickerson J.E.C., Hingorani A.D., Ashby M.J., Palmer C.R., and Brown M.J. Optimisation of anti-hypertensive treatment by crossover rotation of four major classes. Lancet 353 (1999) 2008-2013
18. Falconnet C., Bochud M., Bovet P., Maillard M., and Burnier M. Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent. J Hypertens 22 (2004) 1213-1220
19. Stergiou G.S., Efstathiou S.P., Roussias L.G., and Mountokalakis T.D. Intraindividual blood pressure responses to angiotensin-converting enzyme inhibition and angiotensin receptor blockade. J Clin Hypertens 7 (2005) 18-23
20. Reckelhoff J.F. Gender differences in the regulation of blood pressure. Hypertension 37 (2001) 1199-1208
21. Os I., Oparil S., Gerdts E., and Hoieggen A. Essential hypertension in women. Blood Press 13 (2004) 272-278
22. Safar M.E., and Smulyan H. Hypertension in women. Am J Hypertens 17 (2004) 82-87
23. Curtis K.M., Mohllajee A.P., Martins S.L., and Peterson H.B. Combined oral contraceptive use among women with hypertension: a systematic review. Contraception 73 (2006) 179-188
24. Pechere-Bertschi A., and Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 17 (2004) 994-1001
25. Mueck A.O., and Seeger H. Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women. Maturitas 49 (2004) 189-203
26. Bottini P.B., Carr A.A., Rhoades R.B., and Prisant L.M. Variability of indirect methods used to determine blood pressure: office vs mean 24-hour automated blood pressures. Arch Intern Med 152 (1992) 139-144
27. Staessen J.A., Asmar R., De Buyzere M., Imai Y., Parati G., Shimada K., Stergiou G., Redon J., and Verdecchia P. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit 6 (2001) 355-370
28. Stergiou G.S., Skeva I.I., Baibas N.M., Kalkana C.B., Roussias L.G., and Mountokalakis T.D. Does the antihypertensive response to angiotensin converting enzyme inhibition predict the antihypertensive response to angiotensin receptor antagonism?. Am J Hypertens 14 (2001) 688-693
29. Williams B., Poulter N.R., Brown M.J., Davis M., McInnes G.T., Potter J.F., Sever P.S., McG Thom S., and British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 18 (2004) 139-185
30. Materson B.J., Reda D.J., Cushman W.C., Massie B.M., Freis E.D., Kochar M.S., Hamburger R.J., Fye C., Lakshman R., Gottdiener J., Ramirez E.A., Henderson W.G., and The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 328 (1993) 914-921